Jian Wang - Jun 10, 2024 Form 4 Insider Report for ACM Research, Inc. (ACMR)

Signature
/s/ Mark McKechnie, Attorney-in-Fact for Jian Wang
Stock symbol
ACMR
Transactions as of
Jun 10, 2024
Transactions value $
-$1,075,476
Form type
4
Date filed
6/12/2024, 04:30 PM
Previous filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACMR Class A Common Stock Options Exercise $139K +30K +11.85% $4.62 283K Jun 10, 2024 Direct
transaction ACMR Class A Common Stock Sale -$662K -30K -10.59% $22.07 253K Jun 10, 2024 Direct F1, F2
transaction ACMR Class A Common Stock Options Exercise $139K +30K +11.85% $4.62 283K Jun 11, 2024 Direct
transaction ACMR Class A Common Stock Sale -$651K -28.3K -10% $22.98 255K Jun 11, 2024 Direct F1, F3
transaction ACMR Class A Common Stock Sale -$39.8K -1.68K -0.66% $23.68 253K Jun 11, 2024 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACMR Stock Option Options Exercise $0 -30K -50% $0.00 30K Jun 10, 2024 Class A Common Stock 30K $4.62 Direct F5
transaction ACMR Stock Option Options Exercise $0 -30K -100% $0.00* 0 Jun 11, 2024 Class A Common Stock 30K $4.62 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2024.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.80 to $22.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.44 to $23.40, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.45 to $23.80, inclusive.
F5 The option is fully vested and exercisable.

Remarks:

Chief Executive Officer and President of ACM Research (Shanghai), Inc., a subsidiary of the Issuer